Regulation of HIV-1 transcription

被引:0
|
作者
Roebuck, KA [1 ]
Saifuddin, M [1 ]
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA
来源
关键词
HIV-1; transcription factors; long terminal repeat; Tat; chromatin; promoter; nuclear factor kappa B (NF-kappa B); activator protein-1;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human immunodeficiency virus type-1 (HIV-1) is a highly pathogenic lentivirus that requires transcription of its provirus genome for completion of the viral life cycle and the production of progeny virions. Since the first genetic analysis of HIV-I in 1985, much has been learned about the transcriptional regulation of the HIV-1 genome in infected cells. It has been demonstrated that HIV-I transcription depends on a varied and complex interaction of host cell transcription factors with the viral long terminal repeat (LTR) promoter. The regulatory elements within the LTR interact with constitutive and inducible transcription factors to direct the assembly of a stable transcription complex that stimulates multiple rounds of transcription by RNA polymerase II (RNAPII). However, the majority of these transcripts terminate prematurely in the absence of the virally encoded trans-activator protein Tat, which stimulates HIV-1 transcription elongation by interacting with a stem-loop RNA element (TAR) formed at the extreme 5' end of all viral transcripts. The Tat-TAR interaction recruits a cellular kinase into the initiation-elongation complex that alters the elongation properties of RNAPII during its transit through TAR. This review summarizes our current knowledge and understanding of the regulation of HIV-I transcription in infected cells and highlights the important contributions human lentivirus gene regulation has made to our general understanding of the transcription process.
引用
收藏
页码:67 / 84
页数:18
相关论文
共 50 条
  • [41] Inhibitors of HIV-1 gene expression and transcription
    Baba, M
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 871 - 882
  • [42] Transcription: Insights From the HIV-1 Promoter
    Ne, Enrico
    Palstra, Robert-Jan
    Mahmoudi, Tokameh
    TRANSCRIPTIONAL GENE REGULATION IN HEALTH AND DISEASE, 2018, 335 : 191 - 243
  • [43] Temacrazine inhibits initiation of HIV-1 transcription
    Turpin, JA
    Pallansch, L
    Michejda, C
    Chlody, WC
    Rice, WG
    Buckheit, RW
    ANTIVIRAL RESEARCH, 2000, 46 (01) : A45 - A45
  • [44] Natural endogenous reverse transcription of HIV-1
    Zhang, H
    Dornadula, G
    Pomerantz, RJ
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 41 (1-2) : 255 - 260
  • [45] Hypoxia inhibits HIV-1 transcription.
    Nekhai, Sergei
    Sharroya, Charles
    Ammosova, Tatyana
    Nui, Xiaomei
    Jerebtsova, Marina
    Gordeuk, Victor R.
    BLOOD, 2006, 108 (11) : 382A - 382A
  • [46] INTERACTION OF HIV-1 ONCOPROTEIN WITH TRANSCRIPTION FACTORS
    YOSHIDA, M
    SUZUKI, T
    FUJISAWA, J
    HIRAI, H
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 211 - 211
  • [47] Cellular factors and HIV-1 reverse transcription
    Warren, K.
    Wei, T.
    Li, D. S.
    Warrilow, D.
    Harrich, D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S37 - S37
  • [48] Nuclear organization and the control of HIV-1 transcription
    Marcello, A
    Lusic, M
    Pegoraro, G
    Pellegrini, V
    Beltram, F
    Giacca, M
    GENE, 2004, 326 : 1 - 11
  • [49] Effect of iron chelators on HIV-1 transcription
    Debebe, Zufan Kebede
    Kurantsin-Mills, Joseph
    Ammosova, Tatyana
    Nui, Xiaomei
    Richardson, Des
    Jerebtsova, Marina
    Ray, Patricio
    Gordeuk, Victor
    Nekhai, Sergei
    FASEB JOURNAL, 2007, 21 (06): : A1034 - A1034
  • [50] Modulation of HIV-1 transcription by cytokines and chemokines
    Copeland, KFT
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (12) : 1093 - 1101